3 Stocks Under Investors' Clench - ECT, BGS And MXC

  • Nov 15, 2018 AEDT
  • Team Kalkine
3 Stocks Under Investors' Clench - ECT, BGS And MXC

While the investors were getting concerned over the few declining sessions in the market, the energy sectors’ rebound helped ASX to close higher at 5736 and all ordinaries at 5825. Here are three stocks under the investor’s eyes. This is a good mix of stocks from different sectors to look at.

ENVIRONMENTAL CLEAN TECHNOLOGIES LIMITED (ASX: ECT) – The company in August 2018, for $4 million on the same terms and conditions as the previous facility signed a new Secured Loan Agreement with Brevet for the 2018/19 financial year. The loss for the consolidated entity after providing for income tax amounted to $5,133,685 compared to 30 June 2017 loss of $4,357,282, there were no dividends paid, recommended or declared during the current or previous financial year. The net current assets at the reporting date of $145,046 compared to 2017 net current liabilities of $311,162. The company has advised that the board of NLC India Limited has approved the Research Collaboration Agreement for the Company’s India project. The stock is trading flat at $0.014 as at November 15, 2018. Over the past 12 months period the stock has witnessed a performance change of 55.56%. 

BIRIMIAN LIMITED (ASX: BGS) – With payment of the initial NSR royalty payment of US$280,428 the company received its first mining revenue in early August 2018, compared to A$377,122 during the June Quarter 2018 from Morila for gold produced at the N’tiola Area of Interest. The stock has lower earnings per share (EPS) of -0.029 AUD which reflects the restrained profitability. The cash and cash equivalents at end of period $4.908 million and the company has no debt facility which represents healthy balance sheet and also a working capital surplus of $6,840,152 as compared to December 2017 surplus of $11,546,975. The stock is trading flat at $0.200 as at November 15, 2018. Over the past 60 months period the stock has witnessed a performance change of 70.51%.

MGC PHARMACEUTICALS LTD (ASX: MXC) – To sell 100% of MGC Derma to Canadian private cannabis investment company, the company has signed a formal definitive agreement, trading as CannaGlobal, Cannaglobal Canada Co Inc, following the signing of a Binding Term Sheet. The consolidated loss of the Group from continued operations amounted to $8,990,470 compared to 2017 loss of $8,502,025 following which no dividends have been paid or declared for payment during, or since, the end of the financial year. The year-end cash and cash equivalents balance of $9,858,977 lesser than 2017 cash of $11,363,902. The stock is trading flat at $0.039 as at November 15, 2018 which is very close to its 52-week low. Over the past 60 months period the stock has witnessed a performance change of 330.00%.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.



All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK